1. Home
  2. RFAI vs ALTS Comparison

RFAI vs ALTS Comparison

Compare RFAI & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFAI
  • ALTS
  • Stock Information
  • Founded
  • RFAI 2024
  • ALTS 1976
  • Country
  • RFAI Singapore
  • ALTS United States
  • Employees
  • RFAI N/A
  • ALTS N/A
  • Industry
  • RFAI
  • ALTS
  • Sector
  • RFAI
  • ALTS
  • Exchange
  • RFAI NYSE
  • ALTS NYSE
  • Market Cap
  • RFAI 158.1M
  • ALTS 125.5M
  • IPO Year
  • RFAI 2024
  • ALTS N/A
  • Fundamental
  • Price
  • RFAI $10.56
  • ALTS $6.23
  • Analyst Decision
  • RFAI
  • ALTS
  • Analyst Count
  • RFAI 0
  • ALTS 0
  • Target Price
  • RFAI N/A
  • ALTS N/A
  • AVG Volume (30 Days)
  • RFAI 12.5K
  • ALTS 277.8K
  • Earning Date
  • RFAI 01-01-0001
  • ALTS 08-18-2025
  • Dividend Yield
  • RFAI N/A
  • ALTS N/A
  • EPS Growth
  • RFAI N/A
  • ALTS N/A
  • EPS
  • RFAI 0.33
  • ALTS N/A
  • Revenue
  • RFAI N/A
  • ALTS $18,046,000.00
  • Revenue This Year
  • RFAI N/A
  • ALTS $185.91
  • Revenue Next Year
  • RFAI N/A
  • ALTS $64.93
  • P/E Ratio
  • RFAI $32.44
  • ALTS N/A
  • Revenue Growth
  • RFAI N/A
  • ALTS N/A
  • 52 Week Low
  • RFAI $10.06
  • ALTS $1.29
  • 52 Week High
  • RFAI $10.58
  • ALTS $10.95
  • Technical
  • Relative Strength Index (RSI)
  • RFAI N/A
  • ALTS 36.59
  • Support Level
  • RFAI N/A
  • ALTS $5.98
  • Resistance Level
  • RFAI N/A
  • ALTS $7.60
  • Average True Range (ATR)
  • RFAI 0.00
  • ALTS 0.66
  • MACD
  • RFAI 0.00
  • ALTS -0.11
  • Stochastic Oscillator
  • RFAI 0.00
  • ALTS 11.52

About RFAI RF ACQUISITION CORP II

RF Acquisition Corp II is a blank check company.

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.

Share on Social Networks: